Daniel Alkon
President chez NEUROTROPE, INC.
Fortune : 6 275 $ au 30/04/2024
Postes actifs de Daniel Alkon
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| NEUROTROPE, INC. | Directeur Technique/Scientifique/R&D | 23/08/2013 | - |
| President | 19/09/2016 | - | |
| SYNAPTOGENIX, INC. | Directeur/Membre du Conseil | 07/12/2020 | - |
| Directeur Technique/Scientifique/R&D | - | - | |
| President | - | - |
Historique de carrière de Daniel Alkon
Anciens postes connus de Daniel Alkon
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Blanchette Rockefeller Neurosciences Institute
 Blanchette Rockefeller Neurosciences Institute BiotechnologyHealth Technology Blanchette Rockefeller Neurosciences Institute provides health care solutions. The company offers to facilitate molecular signaling, which controls the functions that record our conscience experience. The company is headquartered in Morgantown, WV. | Directeur Technique/Scientifique/R&D | 01/01/1999 | 23/09/2016 |
| West Virginia University | Corporate Officer/Principal | - | 01/09/2016 |
Adaptive Systems, Inc.
 Adaptive Systems, Inc. Computer Processing HardwareElectronic Technology Adaptive Systems, Inc. manufactures and develops small, high performance modular hardware products for use by the embedded computer industry. It products include 486DX 66MHz, 586-133MHz Processors; System Management; Super I/O, VGA, PCMCIA; and Sound O/S. The company is headquartered in Longmont, CO. | Corporate Officer/Principal | - | - |
| National Institute of Neurological Disorders & Stroke | Directeur Technique/Scientifique/R&D | - | - |
Formation de Daniel Alkon
| University of Pennsylvania | Undergraduate Degree |
| Cornell University | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 9 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 4 |
| President | 2 |
| Corporate Officer/Principal | 2 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 4 |
| Electronic Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SYNAPTOGENIX, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Neurotrope, Inc.
 Neurotrope, Inc. Pharmaceuticals: MajorHealth Technology Neurotrope, Inc. is a biopharmaceutical company, which engages in the pre-clinical and clinical development of its product candidates. The company focuses on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease. It also develops bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X and Niemann-Pick Type C. The company was founded on January 11, 2011 and is headquartered in New York, NY. | Health Technology |
Adaptive Systems, Inc.
Adaptive Systems, Inc. Computer Processing HardwareElectronic Technology Adaptive Systems, Inc. manufactures and develops small, high performance modular hardware products for use by the embedded computer industry. It products include 486DX 66MHz, 586-133MHz Processors; System Management; Super I/O, VGA, PCMCIA; and Sound O/S. The company is headquartered in Longmont, CO. | Electronic Technology |
Blanchette Rockefeller Neurosciences Institute
Blanchette Rockefeller Neurosciences Institute BiotechnologyHealth Technology Blanchette Rockefeller Neurosciences Institute provides health care solutions. The company offers to facilitate molecular signaling, which controls the functions that record our conscience experience. The company is headquartered in Morgantown, WV. | Health Technology |
| National Institute of Neurological Disorders & Stroke | Government |
- Bourse
- Insiders
- Daniel Alkon
- Expérience